Adipotide Peptide: Precision-Targeted Apoptosis for Fat Cell Research and Obesity Studies

Explore Adipotide, a first-in-class peptide for targeted fat cell apoptosis in obesity research.

Get a Quote & Sample

Key Product Advantages

Precision Targeting

The FTPP sequence in Adipotide ensures precise binding to prohibitin receptors on fat cell vasculature, enabling highly specific adipose tissue apoptosis. This specificity is vital for understanding obesity mechanism studies.

High Purity and Verification

Ensuring research integrity, Adipotide is provided with ≥98% purity, rigorously verified by HPLC/MS, and includes batch-specific apoptosis activity data for reliable results.

Research Flexibility

The availability of custom dosage formulations for Adipotide peptide supports diverse preclinical research needs, offering flexibility for various experimental designs in targeted fat reduction.

Key Applications

Obesity Mechanism Studies

Adipotide is instrumental in dissecting the complex mechanisms behind obesity, utilizing its targeted approach to disrupt adipose tissue blood supply.

Metabolic Disease Modeling

Researchers can employ Adipotide to create and study models of metabolic diseases intrinsically linked to obesity, such as type 2 diabetes.

Targeted Fat Reduction Research

This peptide serves as a critical tool for evaluating strategies aimed at selective fat reduction by targeting specific adipose tissue vasculature.

Comparative Therapeutics Evaluation

Adipotide allows for direct comparative analysis against conventional weight-loss approaches, providing valuable insights into therapeutic efficacy.